导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 24.67% | 206/3712 |
| 近一周 | 0.53% | 448/4228 |
| 近一月 | -5.73% | 2968/4196 |
| 近一季 | -13.63% | 3202/4044 |
| 近半年 | 21.84% | 147/3824 |
| 近一年 | 25.84% | 259/3446 |
| 近两年 | 154.69% | 177/2399 |
| 近三年 | 125.58% | 47/1802 |
| 成立以来 | 21.80% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.39% 4231/4961 |
87.42% 140/5312 |
- - |
- - |
| 2025 | 43.10% 679/4813 |
-1.05% 2554/3635 |
-0.61% 2979/4076 |
57.10% 164/4524 |
-7.38% 3793/4813 |
| 2024 | 27.41% 192/3463 |
-4.00% 1594/2808 |
4.26% 223/3014 |
13.79% 2105/3129 |
11.87% 197/3463 |
| 2023 | 1.10% 371/2656 |
16.90% 187/2280 |
-4.39% 1159/2385 |
-8.54% 1707/2515 |
-1.09% 285/2655 |
| 2022 | -37.45% 1755/2207 |
-24.25% 1761/1919 |
-0.27% 1610/2016 |
-19.56% 1787/2113 |
2.92% 803/2208 |
| 2021 | 3.43% 610/1822 |
-14.26% 1171/1255 |
22.87% 122/1330 |
-10.42% 1224/1466 |
9.60% 117/1822 |
| 2020 | - - |
- - |
- - |
- - |
- - |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 华安中证电子50ETF VS. 长安沪深300非周期A(740101) |